OnabotulinumtoxinA effectiveness on chronic migraine, negative emotional states and sleep quality: a single-center prospective cohort study.

Aydinlar E. , Dikmen P. , Kosak S., Kocaman A.

The journal of headache and pain, cilt.18, sa.1, ss.23, 2017 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 18 Konu: 1
  • Basım Tarihi: 2017
  • Doi Numarası: 10.1186/s10194-017-0723-4
  • Dergi Adı: The journal of headache and pain
  • Sayfa Sayıları: ss.23

Özet

Background: OnabotulinumtoxinA (OnabotA) is considered effective in in patients with chronic migraine (CM) who failed on traditional therapies. This study was designed to evaluate the effect of OnabotA injection series on migraine outcome, negative emotional states and sleep quality in patients with CM.